Volume: 30 Issue: 15

1. Clinical diagnosis and treatment of pneumocystis carinii pneumonia in children with blood disease Page:1121—1123
2. Treatment strategies for children with hematonosis and multi-drug resistant bacteria infection Page:1124—1127
3. Diagnosis and treatment of bacterial infection in children with febrile neutropenia Page:1128—1130
4. Treatment of children with highly suspected mature B-cell lymphoblastic leukemia Page:1131—1134
5. Expression significance of Toll-like receptor 4 and myeloid derived suppressor cells in children with acute myeloid leukemia Page:1135—1138
6. Monitoring minimal residual disease by qualitative detection of immunoglobulin H/T cell receptor γ by using multiplex polymerase chain reaction in children with acute lymphocytic leukemia Page:1139—1142
7. Genetic abnormality analysis in 169 childhood acute lymphoblastic leukemia and their response to early treatment Page:1143—1146
8. The unduced effect of arsenic trioxide in different types of neuroblastoma cell lines Page:1164—1167
9. Effect of cardiotrophin-1 mediated by recombinant adenovirus on the neural differentiation of bone marrow mesenchymal stem cells of rats Page:1176—1179
10. Clinical significance on early diagnosis of brain injury in premature infants with multiple sequence joint inspection of magnetic resonance imaging Page:1180—1183
11. Investigation on long-term complications of glucocorticoid in treatment of Diamond-Blackfan anemia Page:1184—1187
12. Progress of the relationship between the etiology of childhood malignancy and placental disease Page:1193—1195
13. Research progress on disialoganglioside as target for immunotherapy of neuroblastoma Page:1196—1198
14. Study on 13-cis retinoic acid inducing differentiation of three types of human neuroblastoma cell lines in vitro Page:1152—1156
15. Effect of Matrine on the expression of X-linked inhibitor of apoptosis protein in human rhabdomyosarcoma RD cells Page:1161—1163
16. Relationship between initial absolute lymphocyte counts and the prognosis of children with primary immune thrombocytopenia Page:1147—1151